John W. Huemoeller II - 02 Jan 2019 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Issuer symbol
AXIM
Transactions as of
02 Jan 2019
Net transactions value
$0
Form type
4
Filing time
23 Sep 2022, 16:11:26 UTC
Next filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Option Award $0 +2,000,000 $0.000000 2,000,000 02 Jan 2019 Common Stock 2,000,000 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 2, 2019, Reporting Person acquired an option to purchase up to 2,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may be purchased at the date which is six (6) months following the grant date.